World Journal of Hepatology - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

JOURNAL HOME

Number of total visits: 2807622

Number of visits today: 313

Number of downloads: 2059309

MEMBERSHIP

BPG JOURNALS

Cited by in F6Publishing

For:	Su X, Li P, Han B, Jia H, Liang Q, Wang H, Gu M, Cai J, Li S, Zhou Y, Yi X, Wei W. Vitamin C sensitizes BRAF^V600E thyroid cancer to PLX4032 via inhibiting the feedback activation of MAPK/ERK signal by PLX4032. J Exp Clin Cancer Res 2021;40:34. [PMID: 33468157 DOI: 10.1186/s13046-021-01831-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]

For:

Su X, Li P, Han B, Jia H, Liang Q, Wang H, Gu M, Cai J, Li S, Zhou Y, Yi X, Wei W. Vitamin C sensitizes BRAF^V600E thyroid cancer to PLX4032 via inhibiting the feedback activation of MAPK/ERK signal by PLX4032. J Exp Clin Cancer Res 2021;40:34. [PMID: 33468157 DOI: 10.1186/s13046-021-01831-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]

Number	Citing Articles
1	Wang X, Jiang W, Du Y, Zhu D, Zhang J, Fang C, Yan F, Chen Z. Targeting feedback activation of signaling transduction pathways to overcome drug resistance in cancer. Drug Resistance Updates 2022;65:100884. [DOI: 10.1016/j.drup.2022.100884] [Reference Citation Analysis]
2	Xiong Y, Xu S, Fu B, Tang W, Zaky MY, Tian R, Yao R, Zhang S, Zhao Q, Nian W, Lin X, Wu H. Vitamin C-induced competitive binding of HIF-1α and p53 to ubiquitin E3 ligase CBL contributes to anti-breast cancer progression through p53 deacetylation. Food Chem Toxicol 2022;168:113321. [PMID: 35931247 DOI: 10.1016/j.fct.2022.113321] [Reference Citation Analysis]
3	Newman M, Connery H, Boyd J. Opioids and Vitamin C: Known Interactions and Potential for Redox-Signaling Crosstalk. Antioxidants 2022;11:1267. [DOI: 10.3390/antiox11071267] [Reference Citation Analysis]
4	Szarka A, Lőrincz T, Hajdinák P. Friend or Foe: The Relativity of (Anti)oxidative Agents and Pathways. IJMS 2022;23:5188. [DOI: 10.3390/ijms23095188] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
5	Huang G, Chen J, Zhou J, Xiao S, Zeng W, Xia J, Zeng X. Epigenetic modification and BRAF gene mutation in thyroid carcinoma. Cancer Cell Int 2021;21. [DOI: 10.1186/s12935-021-02405-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6	Ratajczak M, Gaweł D, Godlewska M. Novel Inhibitor-Based Therapies for Thyroid Cancer-An Update. Int J Mol Sci 2021;22:11829. [PMID: 34769260 DOI: 10.3390/ijms222111829] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
7	Böttger F, Vallés-Martí A, Cahn L, Jimenez CR. High-dose intravenous vitamin C, a promising multi-targeting agent in the treatment of cancer. J Exp Clin Cancer Res 2021;40:343. [PMID: 34717701 DOI: 10.1186/s13046-021-02134-y] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 8.0] [Reference Citation Analysis]